Skip to main content

Table 3 Quality of care indicators generated in the project

From: Development of quality of care indicators from systematic reviews: the case of hospital delivery

  Indicator Target population ICD-9 codesa Indicator formulab Standardc
1 Proportion of women with singleton pregnancies and threatened preterm labour (TPL) who receive corticosteroids25 Women with TPL and preterm labour 644.03, 644.10, 644.13, 644.20, 644.21 D: Singleton pregnancies between 26-34w ≈100
N: Women who received corticoids
E: Corticoids contraindications
2 Proportion of women who are treated with calcium channel blockers (CCB) for inhibiting preterm labour26 Women with TPL and preterm labour 644.03, 644.10, 644.13, 644.20, 644.21 D: Pregnancies between 22-34w ≈100
N: Women who received CCB
E: Contraindication to CCB
3 Proportion of women with threatened preterm labour treated with magnesium sulphate27 Women with TPL and preterm labour 644.03, 644.10, 644.13, 644.20, 644.21 D: Women who received pharmacological treatment for TPL ≈0
N: Women who received magnesium sulphate
E: None
4 Proportion of women with preterm rupture of membranes (PRM) who receive antibiotic treatment28 Women with PRM 658.10, 658.11 D: Pregnancies between 22-34w with PRM ≈100
N: Women who received antibiotics
E: None
5 Proportion of women with post-term pregnancy who give birth after 41 weeks of gestation29 Women with >=41w pregnancy 641.X1, 642.X1, 676.X1 D: Women with > =41w pregnancy ≈0
N: Women with labour induction
E: Spontaneous labour, non-urgent caesarean delivery
6 Proportion of women with severe pre-eclampsia who were treated with magnesium sulphate30 Women with severe preeclampsia 642.5 D: Women with severe pre-eclampsia ≈100
N: Women who received magnesium sulphate
E: Contraindication to magnesium sulphate
7 Proportion of women with eclampsia treated with magnesium sulphate22,23,24 Women with eclampsia 642.6 D: Women with eclampsia ≈100
N: Women who received magnesium sulphate
E: Contraindication to magnesium sulphate
8 Proportion of women with term pregnancies and a breech presentation in which external cephalic version is performed or offered31 Women with breech presentation 73.91 D: Breech presentation ≈100
N: Women in whom cephalic version was performed or offered
E: None
9 Proportion of unjustified episiotomies34 Women in whom episiotomy was performed 73.6 D: Women in who episiotomy was performed ≈0
N: Procedures without any reason documented
E: None
10 Proportion of women whose second-degree perineal tear or episiotomy is repaired with continuous suture35 Women with second-degree perineal tear or episiotomy 664.10, 664.11, 644.14, 73.6 D: Women with second-degree perineal tear or episiotomy ≈100
N: Women in whom continuous suture was performed
E: None
11 Proportion of women who are given an enema during labour36 Women in labour 641.X1, 642.X1, 676.X1 D: Women in labour ≈0
N: Women who were given an enema
E: None
12 Proportion of women having perineal shaving on admission to the delivery room37 Women in labour 641.X1, 642.X1, 676.X1 D: Women in labour ≈0
N: Women for whom perineal shaving was performed
E: None
13 Proportion of women who are administered uterotonics in the third stage of labour38 Women in labour 641.X1, 642.X1, 676.X1 D: Women in labour ≈100
N: Women who received uterotonics
E: Contraindication to uterotonics, patient refusal to receive uterotonics
14 Proportion of women undergoing caesarean section who receive antibiotic therapy39 Women on whom caesarean was performed 74.XX D: Women who received caesarean ≈100
N: Women who received antibiotics
E: None
15 Proportion of women whose peritoneum is sutured at caesarean delivery40 Women on whom caesarean was performed 74.XX D: Women who received caesarean ≈0
N: Women for who peritoneum was sutured
E: None
16 Proportion of health professionals who use double gloves when attending a woman with a blood-borne disease43 Health professionals performing surgical procedures None D: Health professionals who performed surgical procedures in woman with a blood-borne disease ≈100
N: Health professionals who used double gloves
E: None
17 Proportion of Rh-negative women who are given Anti-D within 72 hours after the birth of an Rh-positive or Rh-undetermined baby41 Rh-negative pregnant women None D: Rh-negative women with Rh-positive newborn ≈100
N: Women who received Anti-D
E: Women with prior Rh sensitization.
18 Proportion of women with incomplete miscarriage who, if a surgical evacuation of retained products is carried out, undergo a vacuum aspiration42 Women with incomplete miscarriage 634.X1 -638.X1 D: Women with incomplete miscarriage ≈100
     N: Women in who vacuum aspiration was performed  
     E: Contraindication to vacuum aspiration  
  1. a In this column, the value “X” means any number between 0 to 9.
  2. b In this column, (D) Denominator, (N) Numerator (E) Exclusion criteria.
  3. c Theoretical standards: 100% means a desirable event (higher values indicate appropriate performance) and 0% an undesirable event (lower values indicate inappropriate performance).